BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 19052257)

  • 21. Changes in gastric sodium-iodide symporter (NIS) activity are associated with differences in thyroid gland sensitivity to perchlorate during metamorphosis.
    Carr JA; Murali S; Hu F; Goleman WL; Carr DL; Smith EE; Wages M
    Gen Comp Endocrinol; 2015 Aug; 219():16-23. PubMed ID: 25448256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MEK signaling modulates sodium iodide symporter at multiple levels and in a paradoxical manner.
    Vadysirisack DD; Venkateswaran A; Zhang Z; Jhiang SM
    Endocr Relat Cancer; 2007 Jun; 14(2):421-32. PubMed ID: 17639055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation and tissue distribution of the human sodium iodide symporter gene.
    Ajjan RA; Kamaruddin NA; Crisp M; Watson PF; Ludgate M; Weetman AP
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):517-23. PubMed ID: 9876351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of 99mTc pertechnetate and 131I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo.
    Schipper ML; Riese CGU; Seitz S; Weber A; Béhé M; Schurrat T; Schramm N; Keil B; Alfke H; Behr TM
    Eur J Nucl Med Mol Imaging; 2007 May; 34(5):638-650. PubMed ID: 17160413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
    Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional expression of sodium iodide symporter (NIS) in human breast cancer tissue.
    Upadhyay G; Singh R; Agarwal G; Mishra SK; Pal L; Pradhan PK; Das BK; Godbole MM
    Breast Cancer Res Treat; 2003 Jan; 77(2):157-65. PubMed ID: 12602914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation-induced thyroid stunning: differential effects of (123)I, (131)I, (99m)Tc, and (211)At on iodide transport and NIS mRNA expression in cultured thyroid cells.
    Lundh C; Lindencrona U; Postgård P; Carlsson T; Nilsson M; Forssell-Aronsson E
    J Nucl Med; 2009 Jul; 50(7):1161-7. PubMed ID: 19525464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein.
    Eng PH; Cardona GR; Fang SL; Previti M; Alex S; Carrasco N; Chin WW; Braverman LE
    Endocrinology; 1999 Aug; 140(8):3404-10. PubMed ID: 10433193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number.
    De La Vieja A; Ginter CS; Carrasco N
    J Cell Sci; 2004 Feb; 117(Pt 5):677-87. PubMed ID: 14734652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
    Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
    Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of potential sodium-iodide symporter (NIS) inhibitors using a secondary Fischer rat thyroid follicular cell (FRTL-5) radioactive iodide uptake (RAIU) assay.
    Buckalew AR; Wang J; Murr AS; Deisenroth C; Stewart WM; Stoker TE; Laws SC
    Arch Toxicol; 2020 Mar; 94(3):873-885. PubMed ID: 32065294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The sodium iodide symporter gene and its regulation by cytokines found in autoimmunity.
    Ajjan RA; Watson PF; Findlay C; Metcalfe RA; Crisp M; Ludgate M; Weetman AP
    J Endocrinol; 1998 Sep; 158(3):351-8. PubMed ID: 9846164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Posttranscriptional regulation of sodium-iodide symporter mRNA expression in the rat thyroid gland by acute iodide administration.
    Serrano-Nascimento C; Calil-Silveira J; Nunes MT
    Am J Physiol Cell Physiol; 2010 Apr; 298(4):C893-9. PubMed ID: 20107044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KT5823 differentially modulates sodium iodide symporter expression, activity, and glycosylation between thyroid and breast cancer cells.
    Beyer S; Lakshmanan A; Liu YY; Zhang X; Wapnir I; Smolenski A; Jhiang S
    Endocrinology; 2011 Mar; 152(3):782-92. PubMed ID: 21209020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excess iodide induces an acute inhibition of the sodium/iodide symporter in thyroid male rat cells by increasing reactive oxygen species.
    Arriagada AA; Albornoz E; Opazo MC; Becerra A; Vidal G; Fardella C; Michea L; Carrasco N; Simon F; Elorza AA; Bueno SM; Kalergis AM; Riedel CA
    Endocrinology; 2015 Apr; 156(4):1540-51. PubMed ID: 25594695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inter-species variation in monovalent anion substrate selectivity and inhibitor sensitivity in the sodium iodide symporter (NIS).
    Concilio SC; Zhekova HR; Noskov SY; Russell SJ
    PLoS One; 2020; 15(2):e0229085. PubMed ID: 32084174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydrocortisone and purinergic signaling stimulate sodium/iodide symporter (NIS)-mediated iodide transport in breast cancer cells.
    Dohán O; De la Vieja A; Carrasco N
    Mol Endocrinol; 2006 May; 20(5):1121-37. PubMed ID: 16439463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined Vorinostat and Chloroquine Inhibit Sodium-Iodide Symporter Endocytosis and Enhance Radionuclide Uptake In Vivo.
    Read ML; Brookes K; Zha L; Manivannan S; Kim J; Kocbiyik M; Fletcher A; Gorvin CM; Firth G; Fruhwirth GO; Nicola JP; Jhiang S; Ringel MD; Campbell MJ; Sunassee K; Blower PJ; Boelaert K; Nieto HR; Smith VE; McCabe CJ
    Clin Cancer Res; 2024 Apr; 30(7):1352-1366. PubMed ID: 37921808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iodinated Contrast Agents Perturb Iodide Uptake by the Thyroid Independently of Free Iodide.
    Vassaux G; Zwarthoed C; Signetti L; Guglielmi J; Compin C; Guigonis JM; Juhel T; Humbert O; Benisvy D; Pourcher T; Cambien B
    J Nucl Med; 2018 Jan; 59(1):121-126. PubMed ID: 29051343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells.
    Kogai T; Sajid-Crockett S; Newmarch LS; Liu YY; Brent GA
    J Endocrinol; 2008 Nov; 199(2):243-52. PubMed ID: 18762555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.